Pain after Cesarean Section in spinal anesthesia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Female patients between 18 and 45 years, ASA-Status 1-2, BMI 19-29, that are scheduled for planned caesarean section and have given written informed consent, will be included Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: Exclusion criteria are known allergies or hypersensitivities to evaluated drugs, history of pain syndrome, substance abuse, preeclampsia or eclampsia, deviation from standardised surgical procedure, treatment with magnesium sulfate, renal or hepatic impairment and deviations from the standardized anaesthetic treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: reducing evoked postperative pain after caesarean section;Secondary Objective: reducing total dose, side effects and hyperalgesia in pain treatment after caesarean section;Primary end point(s): Study objective is to evaluate the analgetic and antihyperalgetic potency of oral multi-dose tramadol and acetaminophen in combination and alone after Caesarean Section. In this study the following RESEARCH HYPOTHESIS will be tested: - Combining oral tramadol and acetaminophen is more effective in pain control than the use of tramadol alone - Combining tramadol and acetaminophen for postoperative pain control after Caesarean section reduces side-effects compared to the use of tramadol alone - The dosages of tramadol can be reduced - The combination has an additive antihyperalgetic effect | — |
Countries
Austria